In a new job - May 4, 2021
Cyxone collaborates with world leading rheumatology professor
The company has entered into a collaboration with Professor Costantino Pitzalis, Versus Arthritis Professor of Rheumatology at the William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London. As a world leading expert in pathobiology, translational research and biopsy driven clinical trials, Professor Pitzalis brings invaluable expertise […]
In a new job - April 20, 2021
XNK Therapeutics appoints new CMO and CSO
XNK Therapeutics has announced the appointment of Dr. Johan Aschan as Chief Medical Officer, effective July 1st, and Professor Michael Uhlin as Chief Scientific Officer, effective August 1st. Michael Uhlin will be responsible for defining, implementing, and developing the company’s scientific strategy. He will lead a team involved in R&D and manufacturing with focus on […]
In a new job - April 13, 2021
Capitainer appoints Business Development Manager
Capitainer has announced that Mikael Ström (PhD) has been appointed as Business Development Manager. He joins the team, bringing valuable large scale hospital laboratory expertise, as Capitainer continues to add new applications for their proprietary qDBS dried blood sampling technology, states the company in a press release. Mikael Ström Prior to joining Capitainer, Mikael Ström […]
In a new job - April 3, 2021
Oasmia appoints new Chief Scientific Officer
Oasmia Pharmaceutical has announced the appointment of Reinhard Koenig as Chief Scientific Officer with immediate effect. Koenig is an experienced executive with over 25 years’ experience at life-science companies, many of them operating internationally, states the company in a press release. He has a deep understanding of successful product development and commercialization of medicines in […]
In a new job - April 1, 2021
Elicera appoints new member of the Board
Elicera Therapeutics has announced that Karin Hoogendoorn has been appointed to the Board. The company works for an accelerated development of Elicera’s next generation oncolytic virus and CAR T-cell clinical and pre-clinical programs, together with its iTANK platform for optimizing CAR T-cells. Read more: A new Swedish cell and gene therapy company has been launched […]
In a new job - April 1, 2021
He is the new CEO of Alligator Bioscience
The Board of Directors of the company has appointed Søren Bregenholt as new Chief Executive Officer (CEO). He is appointed to strengthen Alligator’s business development activities and clinical progress on an international level, state the company in a press release. Bregenholt will take up the position on 1 June 2021, succeeding Per Norlén, who will […]
